Biotech Northwest Biotherapeutics Announces $5 Million Convertible Note Financing and Standby Facility for Up to $50 Million Additional Financing December 27, 2024
Biotech Ractigen Therapeutics Announces First Patient Dosed in Phase I Clinical Trial for RAG-17 in SOD1-ALS December 26, 2024
Biotech Global Multiomics Market Expected to Grow Rapidly, with 13.5% Annual Increase from 2024 to 2029 December 25, 2024
Biotech FDA Approves First Generic of Once-Daily GLP-1 Injection to Lower Blood Sugar in Patients with Type 2 Diabetes December 24, 2024